![](/images/graphics-bg.png)
A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel5-FUCDDP
المؤلفون المشاركون
Takachi, Hirokazu
Yoshida, Takahiro
Kawakita, Naoya
Tangoku, Akira
Sawada, Toru
Seike, Junichi
Yuasa, Yasuhiro
Yamai, Hiromichi
Yamamoto, Yota
المصدر
International Journal of Surgical Oncology
العدد
المجلد 2011، العدد 2011 (31 ديسمبر/كانون الأول 2011)، ص ص. 1-7، 7ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2011-08-17
دولة النشر
مصر
عدد الصفحات
7
التخصصات الرئيسية
الملخص EN
Purpose.
Docetaxel/5-FU/CDDP (DFP) therapy is a useful treatment for advanced esophageal cancer.
However, adverse reactions such as chemotherapy-induced nausea and vomiting (CINV) interfere often with continuation of the chemotherapy.
We investigated the efficacy of rikkunshito (TJ-43) on CINV.
Methods.
Nineteen patients who were going to undergo DFP therapy were enrolled.
They were assigned to the following two groups: a TJ-43-treated group and -nontreated group.
The following parameters were compared between the 2 groups: (1) the frequency of symptoms occurred, (2) vomiting, nausea, and anorexia score, and (3) QOL score.
Results.
The incidence of symptoms was lower in the TJ-43-treated group than that in the control group.
The nausea score of the TJ-43-treated group was significantly lower than that of the control group.
In the QOL score, the mood score and the ADL score decreased significantly in the control group.
Conclusion.
We recommend TJ-43 administration in patients undergoing DFP chemotherapy.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Seike, Junichi& Sawada, Toru& Kawakita, Naoya& Yamamoto, Yota& Yuasa, Yasuhiro& Yamai, Hiromichi…[et al.]. 2011. A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel5-FUCDDP. International Journal of Surgical Oncology،Vol. 2011, no. 2011, pp.1-7.
https://search.emarefa.net/detail/BIM-492815
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Seike, Junichi…[et al.]. A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel5-FUCDDP. International Journal of Surgical Oncology No. 2011 (2011), pp.1-7.
https://search.emarefa.net/detail/BIM-492815
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Seike, Junichi& Sawada, Toru& Kawakita, Naoya& Yamamoto, Yota& Yuasa, Yasuhiro& Yamai, Hiromichi…[et al.]. A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel5-FUCDDP. International Journal of Surgical Oncology. 2011. Vol. 2011, no. 2011, pp.1-7.
https://search.emarefa.net/detail/BIM-492815
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-492815
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)